Angiotensin receptor blocker after TAVR for aortic stenosis
Part of Heart & circulation clinical trials.
This study tests whether taking an angiotensin receptor blocker (a type of blood pressure pill) after TAVR helps the heart muscle recover in people with aortic stenosis and thickened heart walls. It's for patients who already had TAVR within the past month and meet safety criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older
- You have severe aortic stenosis with thickened heart muscle (left ventricular hypertrophy)
- You had a successful TAVR procedure within the last 30 days, and your heart function before TAVR was over 40%
- You do not have very low blood pressure (below 90), high potassium, or serious kidney disease (eGFR <30 or on dialysis)
- You are not allergic to angiotensin receptor blockers (like losartan or valsartan)
- You can take medication by mouth and are willing to sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares aspirin and clopidogrel (two blood-thinning medicines) after TAVR to see which is safer or more effective for preventing clots. You may be able to join if you recently had a TAVR for severe aortic valve narrowing and can follow the study plan.
This study tests a new device called the RENATUS® Transcatheter Aortic Valve System for people with severe aortic stenosis. It is designed to replace the narrowed valve without open-heart surgery, and aims to see if it is safe and effective for patients with various surgical risk levels.
This trial compares two approaches for replacing a tight aortic heart valve (TAVI) through a leg artery: doing it with or without a routine check of your heart's arteries (coronary angiogram). If you have severe aortic stenosis and are scheduled for TAVI, this study helps find out whether skipping the artery check is safe and effective.
This trial compares two blood thinners (ticagrelor and aspirin) to see which one works better at preventing blood clots after a less-invasive heart valve replacement (TAVI). It is for people with severe aortic stenosis who also have diabetes, heart disease, or artery disease.
This trial compares different methods to evaluate coronary artery disease in patients planning to have a transcatheter aortic valve replacement (TAVR) for severe aortic stenosis. The goal is to find out if a less invasive approach is as safe and effective as the standard one.
This trial tests a less invasive heart valve replacement (TAVR) for people with a leaky aortic valve (aortic regurgitation). It uses ultrasound guidance to place the new valve, which may offer a treatment option for those who cannot have open-heart surgery.
Hear when a new Left Ventricular Hypertrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.